Page last updated: 2024-10-30

edaravone and Angiogenesis, Pathologic

edaravone has been researched along with Angiogenesis, Pathologic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We investigated the changes in reactive oxygen species (ROS) and angiogenesis through angiotensin II (Ang II) type 1 receptor (AT1R) after the development of acquired platinum resistance in bladder cancer."7.77Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. ( Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Shirakawa, H; Shirotake, S; Tanaka, N, 2011)
"We investigated the changes in reactive oxygen species (ROS) and angiogenesis through angiotensin II (Ang II) type 1 receptor (AT1R) after the development of acquired platinum resistance in bladder cancer."3.77Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. ( Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Shirakawa, H; Shirotake, S; Tanaka, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, N1
Miyajima, A1
Kosaka, T1
Miyazaki, Y1
Shirotake, S1
Shirakawa, H1
Kikuchi, E1
Oya, M1

Other Studies

1 other study available for edaravone and Angiogenesis, Pathologic

ArticleYear
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
    British journal of cancer, 2011, Oct-25, Volume: 105, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antipyrine; Cell Line, Tumor; Cisp

2011